14 results found
Maron E, Lan C-C, Nutt D, 2018, Imaging and Genetic Approaches to Inform Biomarkers for Anxiety Disorders, Obsessive-Compulsive Disorders, and PSTD, BIOMARKERS IN PSYCHIATRY, Editors: Pratt, Hall, Publisher: SPRINGER INTERNATIONAL PUBLISHING AG, Pages: 219-292, ISBN: 978-3-319-99641-7
This chapter was inadvertently published with Fig. 1 which do not belong to this chapter and hence Fig. 1 is deleted from this chapter later.
Haring L, Mottus R, Kajalaid K, et al., 2017, The course of cognitive functioning after first-episode of psychosis: A six month follow-up study, SCHIZOPHRENIA RESEARCH, Vol: 182, Pages: 31-41, ISSN: 0920-9964
Pettai K, Milani L, Tammiste A, et al., 2016, Whole-genome expression analysis reveals genes associated with treatment response to escitalopram in major depression, EUROPEAN NEUROPSYCHOPHARMACOLOGY, Vol: 26, Pages: 1475-1483, ISSN: 0924-977X
Maron E, Wall M, Norbury R, et al., 2015, Effect of short-term escitalopram treatment on neural activation during emotional processing, Journal of Psychopharmacology, Vol: 30, Pages: 33-39, ISSN: 1461-7285
Recent functional magnetic resonance (fMRI) imaging studies have revealed that subchronic medication with escitalopram leads to significantreduction in both amygdala and medial frontal gyrus reactivity during processing of emotional faces, suggesting that escitalopram may have adistinguishable modulatory effect on neural activation as compared with other serotonin-selective antidepressants. In this fMRI study we aimed toexplore whether short-term medication with escitalopram in healthy volunteers is associated with reduced neural response to emotional processing,and whether this effect is predicted by drug plasma concentration. The neural response to fearful and happy faces was measured before and on day7 of treatment with escitalopram (10mg) in 15 healthy volunteers and compared with those in a control unmedicated group (n=14). Significantlyreduced activation to fearful, but not to happy facial expressions was observed in the bilateral amygdala, cingulate and right medial frontal gyrusfollowing escitalopram medication. This effect was not correlated with plasma drug concentration. In accordance with previous data, we showed thatescitalopram exerts its rapid direct effect on emotional processing via attenuation of neural activation in pathways involving medial frontal gyrus andamygdala, an effect that seems to be distinguishable from that of other SSRIs.
Maron E, Nutt D, Shlik J, 2012, Neuroimaging of Serotonin System in Anxiety Disorders, CURRENT PHARMACEUTICAL DESIGN, Vol: 18, Pages: 5699-5708, ISSN: 1381-6128
Aadamsoo K, Saluveer E, Kueuenarpuu H, et al., 2011, Diagnostic stability over 2 years in patients with acute and transient psychotic disorders, NORDIC JOURNAL OF PSYCHIATRY, Vol: 65, Pages: 381-388, ISSN: 0803-9488
Maron E, Toru I, Hirvonen J, et al., 2011, Gender differences in brain serotonin transporter availability in panic disorder, JOURNAL OF PSYCHOPHARMACOLOGY, Vol: 25, Pages: 952-959, ISSN: 0269-8811
Muinos-Gimeno M, Espinosa-Parrilla Y, Guidi M, et al., 2011, Human microRNAs miR-22, miR-138-2, miR-148a, and miR-488 Are Associated with Panic Disorder and Regulate Several Anxiety Candidate Genes and Related Pathways, BIOLOGICAL PSYCHIATRY, Vol: 69, Pages: 526-533, ISSN: 0006-3223
Toru I, Aluoja A, Vohma U, et al., 2010, Associations between personality traits and CCK-4-induced panic attacks in healthy volunteers, PSYCHIATRY RESEARCH, Vol: 178, Pages: 342-347, ISSN: 0165-1781
Maron E, Hettema JM, Shlik J, 2010, Advances in molecular genetics of panic disorder, MOLECULAR PSYCHIATRY, Vol: 15, Pages: 681-701, ISSN: 1359-4184
Baldwin DS, Allgulander C, Altamura AC, et al., 2010, Manifesto for a European Anxiety Disorders Research Network, EUROPEAN NEUROPSYCHOPHARMACOLOGY, Vol: 20, Pages: 426-432, ISSN: 0924-977X
Maron E, Nutt DJ, Kuikka J, et al., 2010, Dopamine transporter binding in females with panic disorder may vary with clinical status, JOURNAL OF PSYCHIATRIC RESEARCH, Vol: 44, Pages: 56-59, ISSN: 0022-3956
Maron E, Toeru I, Hirvonen J, et al., 2010, Brain serotonin transporter availability in panic disorder: Gender differences and implications for treatment response to escitalopram, 27th CINP Congress Meeting 2010, Publisher: CAMBRIDGE UNIV PRESS, Pages: 45-45, ISSN: 1461-1457
This data is extracted from the Web of Science and reproduced under a licence from Thomson Reuters. You may not copy or re-distribute this data in whole or in part without the written consent of the Science business of Thomson Reuters.